U.S. patent application number 14/716507 was filed with the patent office on 2015-11-19 for replacement mitral valve with annular flap.
The applicant listed for this patent is CardiAQ Valve Technologies, Inc.. Invention is credited to Christine Thanh Nguyen, Luca Pesce, Glen Rabito, J. Brent Ratz.
Application Number | 20150328000 14/716507 |
Document ID | / |
Family ID | 53277105 |
Filed Date | 2015-11-19 |
United States Patent
Application |
20150328000 |
Kind Code |
A1 |
Ratz; J. Brent ; et
al. |
November 19, 2015 |
REPLACEMENT MITRAL VALVE WITH ANNULAR FLAP
Abstract
A prosthesis can be configured to grasp intralumenal tissue when
deployed within a body cavity and prevent axial flow of fluid
around an exterior of the prosthesis. The prosthesis can include an
expandable frame configured to radially expand and contract for
deployment within the body cavity, and an annular flap positioned
around an exterior of the expandable frame. In some embodiments,
the annular flap can extend outward from the frame and have a
collapsed configuration and an expanded configuration.
Inventors: |
Ratz; J. Brent; (Winchester,
MA) ; Pesce; Luca; (Huntington Beach, CA) ;
Rabito; Glen; (Lake Forest, CA) ; Nguyen; Christine
Thanh; (Santa Ana, CA) |
|
Applicant: |
Name |
City |
State |
Country |
Type |
CardiAQ Valve Technologies, Inc. |
Irvine |
CA |
US |
|
|
Family ID: |
53277105 |
Appl. No.: |
14/716507 |
Filed: |
May 19, 2015 |
Related U.S. Patent Documents
|
|
|
|
|
|
Application
Number |
Filing Date |
Patent Number |
|
|
62000309 |
May 19, 2014 |
|
|
|
Current U.S.
Class: |
623/2.37 |
Current CPC
Class: |
A61F 2220/005 20130101;
A61F 2/2418 20130101; A61F 2/2445 20130101; A61F 2220/0075
20130101; A61F 2220/0008 20130101; A61F 2250/0039 20130101; A61F
2250/0069 20130101 |
International
Class: |
A61F 2/24 20060101
A61F002/24 |
Claims
1. A prosthesis for placement within a body cavity, the prosthesis
configured to inhibit or reduce paravalvular leakage, the
prosthesis comprising: an expandable frame comprising a proximal
end and a distal end and a longitudinal axis extending
therethrough, the frame configured to radially expand and contract
for deployment within the body cavity; an annular flap positioned
around and secured to an exterior of the expandable frame, the
annular flap having a distal edge secured at or near the distal end
of the frame and extending to a proximal edge secured at an
intermediate location on the frame between the proximal and distal
ends; and a valve body positioned within an interior of the
expandable frame, wherein the valve body comprises: an inner skirt
secured to the interior of the expandable frame; and a plurality of
leaflets configured to allow flow in a first direction and prevent
flow in a second opposite direction; wherein an opening is defined
at or near the distal end of the frame between the annular flap and
the valve body to provide access for fluid to flow into a space
between the annular flap and the valve body, and wherein fluid flow
into the space causes the annular flap to move from a first
configuration wherein the flap is closer to the frame to a second
configuration wherein the flap is spaced further away from the
frame to increase the surface area of the prosthesis and create a
barrier to fluid flow exterior to the frame when deployed within
the body cavity.
2. The prosthesis of claim 1, further comprising a plurality of
distal anchors each connected to the frame so that when the frame
is in an expanded configuration an end of each distal anchor is
positioned radially outward from the frame and extends generally
proximally.
3. The prosthesis of claim 2, wherein at least some of the
plurality of distal anchors comprise a cushion.
4. The prosthesis of claim 1, further comprising a plurality of
proximal anchors each connected to the frame so that when the frame
is in an expanded configuration an end of each proximal anchor is
positioned radially outward from the frame and extends generally
distally.
5. The prosthesis of claim 1, further comprising a band at or near
the proximal end of the frame.
6. The prosthesis of claim 1, wherein the expandable frame
comprises a plurality of struts defining a plurality of
foreshortening cells.
7. The prosthesis of claim 6, wherein the distal edge of the
annular flap is attached to undulating struts at the distal end of
the frame.
8. The prosthesis of claim 1, wherein the intermediate location of
the frame has a greater cross-sectional dimension than the proximal
end and the distal end of the frame when the frame is in an
expanded configuration.
9. The prosthesis of claim 1, wherein the plurality of leaflets are
configured to allow flow from the proximal end to the distal end of
the frame and prevent flow from the distal end to the proximal
end.
10. The prosthesis of claim 1, wherein the annular flap comprises a
first layer of resilient material extending radially outward away
from the frame and a second layer of resilient material extending
distally toward the distal end of the frame.
11. The prosthesis of claim 1, wherein at least a portion of the
expandable frame is positioned within the space between the annular
flap and the valve body.
Description
CROSS-REFERENCE TO RELATED APPLICATIONS
[0001] This application claims priority to U.S. Provisional App.
No. 62/000,309 filed May 19, 2014, titled REPLACEMENT MITRAL VALVE
WITH ANNULAR FLAP, which is hereby incorporated herein by reference
in its entirety and is to be considered a part of this
specification.
BACKGROUND
[0002] 1. Field
[0003] Certain embodiments disclosed herein relate generally to
prostheses for implantation within a lumen or body cavity. In
particular, certain embodiments relate to expandable prostheses
such as replacement heart valves, such as for the mitral valve,
that are configured to atraumatically grasp intralumenal
tissue.
[0004] 2. Background
[0005] Human heart valves, which include the aortic, pulmonary,
mitral and tricuspid valves, function essentially as one-way valves
operating in synchronization with the pumping heart. The valves
allow blood to flow downstream, but block blood from flowing
upstream. Diseased heart valves exhibit impairments such as
narrowing of the valve or regurgitation, which inhibit the valves'
ability to control blood flow. Such impairments reduce the heart's
blood-pumping efficiency and can be a debilitating and life
threatening condition. For example, valve insufficiency can lead to
conditions such as heart hypertrophy and dilation of the ventricle.
Thus, extensive efforts have been made to develop methods and
apparatuses to repair or replace impaired heart valves.
[0006] Prostheses exist to correct problems associated with
impaired heart valves. For example, mechanical and tissue-based
heart valve prostheses can be used to replace impaired native heart
valves. More recently, substantial effort has been dedicated to
developing replacement heart valves, particularly tissue-based
replacement heart valves that can be delivered with less trauma to
the patient than through open heart surgery. Replacement valves are
being designed to be delivered through minimally invasive
procedures and even percutaneous procedures. Such replacement
valves often include a tissue-based valve body that is connected to
an expandable frame that is then delivered to the native valve's
annulus.
[0007] These replacement valves are often intended to at least
partially block blood flow. However, a problem occurs when blood
flows around the valve on the outside of the prosthesis. For
example, in the context of replacement heart valves, paravalvular
leakage has proven particularly challenging. An additional
challenge relates to the ability of such prostheses to be secured
relative to intralumenal tissue, e.g., tissue within any body lumen
or cavity, in an atraumatic manner. Further challenges arise when
trying to controllably deliver and secure such prostheses in a
location such as at a native mitral valve.
SUMMARY OF THE INVENTION
[0008] Embodiments of the present disclosure are directed to a
prosthesis, such as but not limited to a replacement heart valve.
According to some embodiments, a prosthesis can be configured to be
deployed within a body cavity and prevent axial flow of fluid
around an exterior of the prosthesis. The prosthesis can include an
expandable frame configured to radially expand and contract for
deployment within the body cavity, and an annular flap positioned
around an exterior of the expandable frame. Further embodiments are
directed to methods of delivering a prosthesis, e.g. a replacement
heart valve, and methods of using a prosthesis to create a barrier
to fluid flow exterior to the prosthesis (e.g., to prevent
paravalvular leakage).
[0009] In some embodiments, the prosthesis can include an
expandable frame having a proximal end and a distal end and a
longitudinal axis extending therethrough. In some embodiments, the
frame can be designed to radially expand and contract for
deployment within the body cavity. The prosthesis can include an
annular flap positioned around and secured to an exterior of the
frame. The annular flap may have a distal edge secured at or near
the distal end of the frame and extending to a proximal edge
secured at an intermediate location on the frame between the
proximal and distal ends. The prosthesis can include a valve body
positioned within an interior of the expandable frame. In some
embodiments, the valve body can include an inner skirt secured to
the interior of the expandable frame and a plurality of leaflets
designed to allow flow in a first direction and prevent flow in a
second opposite direction. In some embodiments, an opening is
defined at or near the distal end of the frame between the annular
flap and the valve body which can provide access for fluid to flow
into a space between the annular flap and the valve body. In some
embodiments, the fluid flow into the space can cause the annular
flap to move from a first configuration wherein the flap is closer
to the frame to a second configuration wherein the flap is spaced
further away from the frame to increase the surface area of the
prosthesis and create a barrier to fluid flow exterior to the frame
when deployed within the body cavity.
BRIEF DESCRIPTION OF THE DRAWINGS
[0010] FIG. 1A is a proximal oriented, perspective view of an
embodiment of a prosthesis illustrating a frame, a plurality of
anchors, a band, a flap, and a valve body.
[0011] FIG. 1B is a distal oriented, perspective view of the
prosthesis of FIG. 1A.
[0012] FIG. 2 is a front elevation view of the prosthesis of FIG.
1.
[0013] FIG. 3 is a front elevation view of another embodiment of a
prosthesis.
[0014] FIG. 4 is a front elevation view of an embodiment of a
frame.
[0015] FIG. 5 is a perspective view of an embodiment of an annular
flap.
[0016] FIG. 6 is a front elevation view of the annular flap of FIG.
5.
[0017] FIG. 7 is a perspective view of an embodiment of a valve
body.
[0018] FIG. 8 is a front perspective view of the valve body of FIG.
7.
[0019] FIG. 9 is a front elevation of an embodiment of a prosthesis
illustrating a frame, a plurality of anchors, a band, a flap, and a
valve body.
[0020] FIG. 10 is a front elevation another embodiment of a
prosthesis.
[0021] FIG. 11A is a partial cross-sectional view of the prosthesis
of FIG. 1 with the annular flap in a first configuration.
[0022] FIG. 11B is a partial cross-sectional view of the prosthesis
of FIG. 11A with the annular flap in a first configuration.
[0023] FIG. 12A is a partial cross-sectional view of the prosthesis
of FIG. 1 with the annular flap in a first configuration, the valve
body being removed.
[0024] FIG. 12B is a partial cross-sectional view of the prosthesis
of FIG. 12A with the annular flap in a first configuration.
[0025] FIG. 13A-15 illustrate schematic representations of the
prosthesis of FIG. 3 positioned within a heart, with FIGS. 13A-13C
illustrating the prosthesis in situ with distal anchors contacting
the ventricular side of a mitral valve annulus, FIGS. 14A-14B
illustrating the prosthesis in situ with distal anchors not
contacting the ventricular side of the mitral valve annulus, and
FIG. 15 illustrating the prosthesis in situ with distal anchors not
extending between the chordae tendineae.
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0026] The embodiment of FIGS. 1A-4 illustrates a prosthesis 10.
The prosthesis 10 can have components, features, and/or
functionality similar to those described in any of U.S. Publication
Nos. 2014/0277390, 2014/0277422, and 2014/0277427, the entire
contents of all which are incorporated by reference herein. With
reference first to the embodiments of FIGS. 1A-4, the prosthesis 10
can include a frame 20, anchors 30, 34, a band 40, an annular flap
or sail 50 and a valve body 60. The prosthesis 10 can include a
proximal end 12 and a distal end 14 with openings defined at both
ends 12, 14 such that fluid can flow therethrough. In some
embodiments, the proximal end 12 can be placed in the left atrium
while the distal end 14 can be placed in the left ventricle such
that prosthesis 10 can function as a replacement for a mitral
valve. As will be discussed in greater detail below and as
discussed in U.S. Publication Nos. 2014/0277390, 2014/0277422, and
2014/0277427, the prosthesis 10 can allow blood flow in a first
direction from the proximal end 12 to the distal end 14 while
preventing blood flow in a second direction from the distal end 14
to the proximal end 12. For example, during diastole the valve body
60 may be open to allow blood flow from the proximal end 12 to the
distal end 14, and during systole the valve body 60 may be closed
to prevent blood flow from the distal end 14 to the proximal end
12.
[0027] With reference now to the embodiment of FIG. 4, the
embodiment illustrates an expandable frame 20 of the prosthesis 10
which can have a proximal end 22 and a distal end 24. In some
embodiments, such as the illustrated embodiment, the frame 20 can
include an intermediate portion 26 which has a greater diameter
than the diameter of the frame 20 at the proximal and/or distal
ends 22, 24 when the frame 20 is in an expanded configuration. In
some embodiments, such as the illustrated embodiment, the frame 20
can include an intermediate portion 26 which has a greater
cross-sectional area than the cross-sectional area of the frame 20
at the proximal and/or distal ends 22, 24 when the frame 20 is in
an expanded configuration. The frame 20 can be designed to expand
radially and contract for deployment within a body cavity, such as
at a heart valve location such as the mitral valve. For example, as
described in greater detail in U.S. Publication Nos. 2014/0277390,
2014/0277422, and 2014/0277427, the frame 20 can include a
plurality of struts which define a plurality of foreshortening
cells. In some embodiments, the frame 20 can be designed to
radially and contract radially from a longitudinal axis 28
extending through the frame 20. As illustrated in the embodiments
of FIGS. 1-4, the proximal end 22 can define a proximal opening 23
and the distal end 24 can define a distal opening 25.
[0028] With continued reference to the embodiments of FIGS. 1A-4
which illustrates the prosthesis 10, in some embodiments the
prosthesis 10 can include one or more distal anchors 30. The distal
anchors 30 can be positioned along or proximate a distal end 24 of
the frame 20 and can be connected to the frame 20. The distal
anchors 30 can be designed such that when the frame 20 is in an
expanded configuration an end or tip 32 of each distal anchor 30 is
positioned radially outward from the frame 20 and extends generally
in a proximal direction. In some embodiments, the prosthesis 10 can
include one or more proximal anchors 34. The proximal anchors 34
can be positioned along or proximate a proximal end 22 of the frame
20 and can be connected to the frame 20. The proximal anchors 34
can be designed such that when the frame 20 is in an expanded
configuration an end or tip 36 of each proximal anchor 34 is
positioned radially outward from the frame 20 and extends generally
in a distal direction. In some embodiments, one or more anchors 30,
34 can include cushions 38, 39 covering one or more of such
anchors.
[0029] In some embodiments, the cushion 38 can be formed from two
separate pieces of material such as an inner portion positioned
within a covering such that the covering forms a layer surrounding
the inner portion. For example, the inner portion can be wholly
contained within the covering. In some embodiments, the inner
portion can be formed of a foam material such that the inner
portion is at least somewhat compliant and the covering can be
formed of a biocompatible, fabric material. The embodiment of FIGS.
1A, 1B and 2 illustrates cushions 38 on alternating distal anchors
30, the cushions 38 extending partially from an end or tip of the
anchor 30 towards the connection between the anchor 30 and the
frame 20. Use of cushions 38 on alternating distal anchors 30 can
maintain a smaller form factor while in the prosthesis 10 is in a
contracted state for delivery. As such, for embodiments having
twelve distal anchors 30, a total of six distal anchors 30 can have
cushions 38 and a total of six distal anchors 30 may not have a
cushion 38. The cushions 38 can advantageously increase contact
area of the anchors 30 on tissue. This can reduce trauma between
the anchor 30 and such tissue. Moreover, this can facilitate growth
of tissue in and/or around the anchor 30 in embodiments where the
cushions 38 are formed of a material which encourages tissue
growth. The cushions 38 on anchors 30 adjacent anchors 30 without a
cushion 38 can also beneficially reduce any potential trauma caused
by adjacent anchors 30 without a cushion 38.
[0030] The embodiment of FIG. 3 illustrates cushions 38, 39 on all
distal anchors 30. As shown some of the distal anchors 30 include
thicker cushions 38 than other distal anchors 30. The cushions 38,
39 can extend the majority or entirety of the length of the anchor
30 from an end or tip of the anchor 30 towards the connection
between the anchor 30 and the frame 20. As shown, two distal
anchors 30 include thicker cushions 38 with a distal anchor 30
having a thinner cushion 39 positioned therebetween. As such, for
embodiments having twelve distal anchors 30, a total of eight
distal anchors 30 can have thicker cushions 38 and a total of four
distal anchors 30 can include thinner cushions 39. The thicker
cushions 38 can be formed of an inner portion and a cover layer,
with the inner portion being formed from a compliant material, such
as foam, and the covering can be formed of a biocompatible, fabric
material. As shown, the inner portion can be positioned only around
a portion of the anchor 30 whereas the covering can extend the
majority or entirety of the length of the anchor 30. The thinner
cushion 39 can be a cover layer with a thinner inner portion or
without an inner portion. The inner portion and/or the covering can
be formed of a material which encourages tissue growth.
[0031] Other configurations of cushions 38, 39 can also be used.
For example, in some embodiments, the cushions 38, 39 can be
included on proximal anchors 34. In some embodiments, the cushions
38, 39 can be positioned on other portions of the frame 20 such as,
but not limited to, one or more of the struts forming the frame 20.
The cushions 38, 39 can advantageously increase contact area of the
prosthesis 10 on tissue. This can reduce trauma between the frame
20 and such tissue. Moreover, this can facilitate growth of tissue
in and/or around the frame 20 in embodiments where the cushions 38,
39 are formed of a material which encourages tissue growth. In some
embodiments, the covering of cushions 38, 39 can extend from the
annular flap 50 and be formed from materials similar to those of
the annular flap 50. The covering of cushions 38, 39 can cover a
majority or the entirety of the distal anchors 30 as shown in FIG.
3. In some embodiments, the cushions 38, 39 can be attached to the
distal anchors 30 via circumferential stitching about a
longitudinal axis of the distal anchor 30.
[0032] With reference to the embodiments of FIGS. 1A-3, in some
embodiments the prosthesis 10 can include a band 40 along or
proximate the proximal end 22 of the frame 20. The band 40 can
include features and perform functions similar to those described
in U.S. patent application Ser. No. 13/403,929 filed Feb. 23, 2012,
titled REPLACEMENT VALVE AND METHOD, published as U.S. Publication
No. 2012/0215303, the entire contents of which is incorporated by
reference herein.
[0033] With reference to the embodiments of FIGS. 1A-3, 5 and 6,
the prosthesis 10 can include an annular flap 50 which can be
positioned around and secured to an exterior of the frame 20. The
annular flap 50 can have a distal edge 52 secured at or proximate
the distal end 24 of the frame 20 and extend to a proximal edge 54
secured at or proximate an intermediate location, such as the
intermediate portion 26, on the frame 20 between the proximal and
distal ends 22, 24. In some embodiments, the distal edge 52 of the
annular flap 50 can be provided with a shape that generally
corresponds to the shape of the frame 20. This can facilitate the
securement of the flap 50 to the frame 20. For example, as
illustrated in the embodiments of FIGS. 1A-3, 5 and 6, the distal
edge 52 can include a generally triangular pattern 56 which follows
the generally triangular, zig-zag or undulating pattern of the
struts of frame 20 along the distal end 24 of frame 20. Other
shapes and/or patterns 56 can be used along the distal edge 52 of
the annular flap 50. In some embodiments, the distal edge 52 of the
annular flap 50 can have no pattern. In some embodiments the distal
edge 52 does not follow the pattern of the struts of the frame 20
and/or can have a different pattern from that of the struts.
[0034] In some embodiments, such as the embodiments of FIGS. 1A-3,
5 and 6, the annular flap 50 can have a flange 58. The flange 58
can extend generally radially outward in a direction generally
orthogonal to the longitudinal axis 28 extending through the frame
20. In some embodiments, the flange 58 can also project proximally
and/or distally. The flange 58 can be used to further prevent or
inhibit backflow of fluids around the prosthesis 10. In some
embodiments, the flange 58 can be formed from a first layer of
resilient material, such as polyethylene terephthalate (PET) or any
other biocompatible material, which extends radially outward from
the frame 10. In some embodiments, a second layer of resilient
material, such as PET or any other biocompatible material, can
extend from the first layer in a distal direction towards a distal
end 24 of the frame 20. In some embodiments, the first and second
layers can be connected together using a suitable mechanism such as
adhesives or sutures. In some embodiments, the annular flap 50 can
be formed from a single layer of resilient material. In some
embodiments, the first and/or second layers can be formed from a
deformable material. In some embodiments, the first and/or second
layers can be formed from a material which is wholly or
substantially fluid impermeable. The annular flap 50 can also
include other structures, such as wires formed from resilient
materials such as nitinol, to allow at least portions of the
annular flap 50 to retain a particular shape. These structures may
be positioned on an inner surface of the annular flap 50.
[0035] In some embodiments, the flange 58 can be formed when the
annular flap 50 is in an expanded configuration. When the flap is
in an expanded configuration, such as illustrated in the embodiment
of FIG. 6, the radius of the annular flap 50 can decrease distal of
the flange 58. As will be described in further detail below, the
annular flap 50 can have a first, collapsed or deflated
configuration in which the flap 50 is closer to the frame 20 to a
second, expanded or inflated configuration in which the flap 50 is
spaced further away from the frame 20. The expanded configuration
can increase the surface area of the prosthesis 10 and create a
barrier to fluid flow exterior to the frame 20 when deployed within
a body cavity. The transition from the first configuration to the
second configuration, and from the second configuration to the
first configuration, can be triggered by blood flow into and out of
the interior region of the flap 50, as described further below.
[0036] With reference to the embodiments of FIGS. 1A-3 and 7-10,
the prosthesis 10 can include a valve body 60 positioned within an
interior of the frame 20. In some embodiments, the valve body 60
can include an inner skirt 62 secured to the interior of the frame
20. The valve body 60 can include a plurality of leaflets 64 which
can be designed to allow flow in a first direction, such as a
proximal to distal direction, while preventing flow in a second
direction, such as a distal to proximal direction. In some
embodiments, the leaflets 64 have a curved, proximal edge which is
fixed to the inner skirt 62 and a distal edge which freely moves.
In such embodiments, movement of the distal edges towards and away
from each other can allow the valve body 60 to open and close
depending on the direction of flow. Accordingly, the valve body 60
can function as a one-way valve such as a mitral valve. In some
embodiments, the leaflets 64 are secured to the inner skirt 62. The
leaflets 64 and the inner skirt 62 can be manufactured from the
same material or from different materials. For example, the inner
skirt 62 can be manufactured from a more rigid material than the
leaflets 64. In some embodiments, the distal end 66 of the inner
skirt 62 can be secured at or proximate the distal end 24 of the
frame 20. In some embodiments, such as is illustrated in the
embodiments of FIGS. 9 and 10, the distal end 66 of the inner skirt
62 can be positioned slightly proximal of the distal end 24 of the
frame 20. This can allow facilitate blood flow around the outside
of the inner skirt 62 and into the annular flap 50. The inner skirt
62 can include one or more openings or cutouts 67 positioned along
a distal end 66 of the inner skirt 62. This can further facilitate
blood flow around the outside of the inner skirt 62. In some
embodiments, the valve body 60 can include arms 68 to further
secure the valve body 60 to the frame 20.
[0037] Reference is now made to the embodiments of FIGS. 11A-B and
12A-B which illustrate two configurations of the annular flap. It
should be noted that the embodiment of FIGS. 12A-B is similar to
the embodiment of FIG. 11A-B with the valve body 60 removed. As
shown in the embodiments of FIGS. 11A and 12A, in a first
configuration the annular flap 50 is positioned closer to the frame
20. In the event that fluid flows in a second direction, such as a
distal to proximal direction, at least a portion of the fluid can
enter into an opening between the frame 20 and the annular flap 50,
such as opening or cutout 67 formed along the distal end 66 of the
inner skirt 62, and collect within a space 59 such that the annular
flap 50 takes on the second configuration as shown in the
embodiments of FIGS. 11B and 12B. As shown in the embodiments of
FIG. 1B, the frame 20 can be positioned within the space 59 between
the annular flap 50 and the valve body 60. This effect can be
enhanced if the valve body 60 is designed to prevent fluid flow in
the second direction (e.g., distal to proximal), such that a
substantial portion of fluid is forced around and into the annular
flap 50. The annular flap 50 can revert back to the first
configuration when fluid flows in a first direction, such as a
proximal to distal direction, such that fluid is expelled from
within the space 59. In some embodiments, the space 59 can be
formed between the inner skirt 62 and the flap 50. For example,
both the inner skirt 62 and the flap 50 can be connected to the
frame 20 along this region, such as along a proximal edge 54 of the
flap 50, such that the inner skirt 62 and flap 50 serve as a
barrier to flow of fluid outward from space 59.
[0038] Reference is now made to FIG. 13A-15 which illustrate
schematic representations of an embodiment of a replacement heart
valve 10 positioned within a native mitral valve of a heart 100. A
portion of the native mitral valve is shown schematically and
represents typical anatomy, including a left atrium 102 positioned
above an annulus 106 and a left ventricle 104 positioned below the
annulus 106. The left atrium 102 and left ventricle 104 communicate
with one another through a mitral annulus 106. Also shown
schematically in FIGS. 13A-15 is a native mitral leaflet 108 having
chordae tendineae 110 that connect a downstream end of the mitral
leaflet 108 to the papillary muscle of the left ventricle 104. The
portion of the replacement heart valve 10 disposed upstream of the
annulus 106 (toward the left atrium) can be referred to as being
positioned supra-annularly. The portion generally within the
annulus 106 is referred to as positioned intra-annularly. The
portion downstream of the annulus 106 is referred to as being
positioned sub-annularly (toward the left ventricle). In the
illustrated embodiment, only a part of the foreshortening portion
is positioned intra-annularly or sub-annularly, and the rest of the
replacement heart valve 10 is supra-annular.
[0039] As shown in the situations illustrated in FIGS. 13A-14, the
replacement heart valve 10 can be disposed so that the mitral
annulus 106 is between the distal anchors 30 and the proximal
anchors 34. In some situations, the prosthesis 10 can be positioned
such that ends or tips 32 of the distal anchors 30 contact the
annulus 106 as shown, for example, in FIGS. 13A-13C. In some
situations, the prosthesis 10 can be positioned such that ends or
tips 32 of the distal anchors 30 do not contact the annulus 106 as
shown, for example, in FIGS. 14A-14B. In some situations, the
prosthesis 10 can be positioned such that the distal anchors 30 do
not extend around the leaflet 108 as shown in FIG. 15. While FIGS.
13A-15 are described separately below, it should be understood that
one or more of the situations illustrated in FIGS. 13A-15 may be
present when the prosthesis 10 is positioned at the implantation
location, such as a native mitral valve. For example, in some
situations the prosthesis 10 may be positioned such that some
distal anchors 30 may contact the annulus 106 while other distal
anchors 30 may not.
[0040] With reference first to the situations illustrated in FIGS.
13A-14B, the replacement heart valve 10 can be positioned so that
the ends or tips 32 of the distal anchors 30 are on a ventricular
side of the mitral annulus 106 and the ends or tips of 36 the
proximal anchors 34 are on an atrial side of the mitral annulus
106. The distal anchors 30 can be positioned such that the ends or
tips 32 of the distal anchors 30 are on a ventricular side of the
native leaflets beyond a location where chordae tendineae 110
connect to free ends of the native leaflets. The distal anchors 30
may extend between at least some of the chordae tendineae 110 and,
in some situations such as those shown in FIGS. 13A-13C, can
contact or engage a ventricular side of the annulus 106. It is also
contemplated that in some situations, such as those shown in FIGS.
14A and 14B, the distal anchors 30 may not contact the annulus 106,
though the distal anchors 30 may still contact the native leaflet
108. In some situations, the distal anchors 30 can contact tissue
of the left ventricle 104 beyond the annulus 106 and/or a
ventricular side of the leaflets.
[0041] During delivery, the distal anchors 30 (along with the frame
20) can be moved toward the ventricular side of the annulus 106
with the distal anchors 30 extending between at least some of the
chordae tendineae 110 to provide tension on the chordae tendineae
110. The degree of tension provided on the chordae tendineae 110
can differ. For example, little to no tension may be present in the
chordae tendineae 110 as shown in FIG. 13C where the leaflet 108 is
shorter than or similar in size to the distal anchors 30. A greater
degree of tension may be present in the chordae tendineae 110 as
shown in FIGS. 13A and 13B where the leaflet 108 is longer than the
distal anchors 30 and, as such, takes on a compacted form and is
pulled proximally. An even greater degree of tension may be present
in the chordae tendineae 110 as shown in FIGS. 14A and 14B where
the leaflets 108 are even longer relative to the distal anchors 30.
As shown in FIGS. 14A and 14B, the leaflet 108 is sufficiently long
such that the distal anchors 30 do not contact the annulus 106.
[0042] The proximal anchors 34 can be positioned such that the ends
or tips 36 of the proximal anchors 34 are adjacent the atrial side
of the annulus 106 and/or tissue of the left atrium 102 beyond the
annulus 106. In some situations, some or all of the proximal
anchors 34 may only occasionally contact or engage atrial side of
the annulus 106 and/or tissue of the left atrium 102 beyond the
annulus 106. For example, as shown in FIGS. 13A and 13B, the
proximal anchors 34 may be spaced from the atrial side of the
annulus 106 and/or tissue of the left atrium 102 beyond the annulus
106. The proximal anchors 34 could provide axial stability for the
prosthesis 10. In some situations such as those shown in FIGS. 13A
and 14A, some or all of the proximal anchors 34 may not contact the
annular flap 50. This may occur when the annular flap 50 is in a
collapsed configuration although it may also occur when the annular
flap 50 is in an expanded configuration. In some situations such as
those shown in FIGS. 13B, 13C and 14B, some or all of the proximal
anchors 34 may contact the annular flap 50. This may occur when the
annular flap 50 is in an expanded configuration although it may
also occur when the annular flap 50 is in a collapsed
configuration. It is also contemplated that some or all of the
proximal anchors 34 may contact the atrial side of the annulus 106
and/or tissue of the left atrium 102 beyond the annulus 106
[0043] With continued reference to the situations illustrated in
FIGS. 13A-14B, the annular flap 50 can be positioned such that a
proximal portion 51 of the annular flap 50 is positioned along or
adjacent an atrial side of the annulus 106. The proximal portion 51
can be positioned between the atrial side of the annulus 106 and
the proximal anchors 34. The proximal portion 51 can extend
radially outward such that the annular flap 50 is positioned along
or adjacent tissue of the left atrium 102 beyond the annulus 106.
The annular flap 50 can create a seal over the atrial side of the
annulus 106 when the flap 50 is in the expanded state.
[0044] The flap 50 can transition from the collapsed state to the
expanded state during systole when pressure in the left ventricle
104 increases. This increased pressure within the left ventricle
104 can cause blood within the left ventricle 104 to be directed to
areas of lower pressure, such as the aorta (not shown) and the left
atrium 102. As noted above, during systole the valve body 60 may be
closed to prevent blood from flowing back into the left atrium 102.
A substantial portion of blood can forced around the frame 20 and
valve body 60 and into the annular flap 50 such that the flap 50
can expand. Sealing along an atrial side of the annulus 106 can be
particularly effective. The left atrium 102 can be at a lower
pressure in comparison to the pressure of the space 59 between the
annular flap 50 and the valve body 50, which is closer to the
pressure of the left ventricle 104. The existence of such a
pressure differential between the left atrium 102 and the space 59
during systole can allow the flap 50 to apply a greater force to
surrounding tissue within the left atrium 102. During diastole,
where blood flows from the left atrium 102 towards the left
ventricle 104, the flap 50 can transition from the expanded state
back to the collapsed state.
[0045] In some situations such as those shown in FIGS. 13A and 14A,
the annular flap 50 may not contact the wall of the heart 100. This
may occur when the annular flap 50 is in a collapsed configuration
although it may also occur when the annular flap 50 is in an
expanded configuration. In some situations such as those shown in
FIGS. 13B, 13C and 14B, the annular flap 50 may contact the wall of
the heart 100. This may occur when the annular flap 50 is in an
expanded configuration although it may also occur when the annular
flap 50 is in a collapsed configuration. As shown in FIG. 13A-14B,
the annular flap 50 can also assist in filling gaps which exist
between the leaflet 108 and the frame 20 (portions of which are
illustrated in dashed lines).
[0046] In some situations such as that shown in FIG. 15, the
leaflet 108 may not be captured between the frame 20 (portions of
which are shown in dashed lines) and the distal anchors 30. As
shown, the anchor 30 may be positioned along an atrial surface of
the leaflet 108. The anchor 30 may also be positioned along an
inner surface of the annulus 106. It is also contemplated that the
anchor 30 may exert a force against the leaflet 108 such that the
leaflet 108 is pushed radially outward, relative to the
longitudinal axis 28, towards a wall of the heart 100. In such
situations, the flap 50 can create a seal intra-annularly and/or
along an atrial side of the leaflet 108. In alternative situations
(not shown), the flap 50 can create a seal along a ventricular side
of the annulus 106. For example, the replacement heart valve 10 may
be disposed in the mitral annulus such that a portion of the
annular flap 50 is positioned on the ventricular side of the native
annulus 106.
[0047] As noted above, although the in vivo situations of FIG.
13A-15 have been described separately, it should be understood that
one or more of these situations may be present when a prosthesis is
positioned at the implantation location, such as a native mitral
valve. For example, one or more of the distal anchors 30 may not
capture the leaflet 108 whereas the remaining anchors 30 may
capture the leaflet 108. As another example, when the prosthesis 10
is positioned within the native mitral valve, the annular flap 50
can contact the wall of the heart 100 along one or more portions of
an outermost circumference of the proximal portion 51 and may not
contact the wall of the heart 100 along other portions of the
outermost circumference of the proximal portion 51. For example,
the annular flap 50 may contact the wall of the heart 100 along an
approximately 180 degree portion of the outermost circumference of
the proximal portion 51 and may not contact the wall of the heart
100 along the remaining, approximately 180 degree portion of the
outermost circumference of the proximal portion 51.
[0048] Replacement heart valves can be delivered to a patient's
heart mitral valve annulus in various ways, such as by open
surgery, minimally-invasive surgery, and percutaneous or
transcatheter delivery through the patient's vasculature. In some
embodiments, the replacement heart valve can be delivered
transapically or transfemorally.
[0049] Although this invention has been disclosed in the context of
certain preferred embodiments and examples, it will be understood
by those skilled in the art that the present invention extends
beyond the specifically disclosed embodiments to other alternative
embodiments and/or uses of the invention and obvious modifications
and equivalents thereof. In addition, while a number of variations
of the invention have been shown and described in detail, other
modifications, which are within the scope of this invention, will
be readily apparent to those of skill in the art based upon this
disclosure. It is also contemplated that various combinations or
sub-combinations of the specific features and aspects of the
embodiments may be made and still fall within the scope of the
invention. Accordingly, it should be understood that various
features and aspects of the disclosed embodiments can be combined
with or substituted for one another in order to form varying modes
of the disclosed invention. Thus, it is intended that the scope of
the present invention herein disclosed should not be limited by the
particular disclosed embodiments described above, but should be
determined only by a fair reading of the claims that follow.
[0050] Similarly, this method of disclosure is not to be
interpreted as reflecting an intention that any claim require more
features than are expressly recited in that claim. Rather, as the
following claims reflect, inventive aspects lie in a combination of
fewer than all features of any single foregoing disclosed
embodiment. Thus, the claims following the Detailed Description are
hereby expressly incorporated into this Detailed Description, with
each claim standing on its own as a separate embodiment.
* * * * *